journal
MENU ▼
Read by QxMD icon Read
search

CA: a Cancer Journal for Clinicians

journal
https://www.readbyqxmd.com/read/30475405/perioperative-management-may-lead-to-less-pain-after-breast-cancer-surgery
#1
Mike Fillon
No abstract text is available yet for this article.
November 26, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30475387/surgery-remains-the-best-solution-for-patients-with-soft-tissue-sarcomas
#2
Mike Fillon
No abstract text is available yet for this article.
November 26, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30457670/follow-the-trail-using-insights-from-the-growth-of-palliative-care-to-propose-a-roadmap-for-cancer-rehabilitation
#3
Kathleen D Lyons, Lynne S Padgett, Timothy F Marshall, Joseph A Greer, Julie K Silver, Vishwa S Raj, David S Zucker, Jack B Fu, Mackenzi Pergolotti, Alix G Sleight, Catherine M Alfano
Despite research explicating the benefits of cancer rehabilitation interventions to optimize physical, social, emotional, and vocational functioning, many reports document low rates of referral to and uptake of rehabilitation in oncology. Cancer rehabilitation clinicians, researchers, and policy makers could learn from the multidisciplinary specialty of palliative care, which has benefited from a growth strategy and has garnered national recognition as an important and necessary aspect of oncology care. The purpose of this article is to explore the actions that have increased the uptake and integration of palliative care to yield insights and multimodal strategies for the development and growth of cancer rehabilitation...
November 20, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30452086/a-blueprint-for-cancer-screening-and-early-detection-advancing-screening-s-contribution-to-cancer-control
#4
Richard C Wender, Otis W Brawley, Stacey A Fedewa, Ted Gansler, Robert A Smith
From the mid-20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk-based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state-of-the art care at each crucial step in the cascade of events that characterize successful cancer screening...
November 19, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30376182/equitably-improving-outcomes-for-cancer-survivors-and-supporting-caregivers-a-blueprint-for-care-delivery-research-education-and-policy
#5
Catherine M Alfano, Corinne R Leach, Tenbroeck G Smith, Kim D Miller, Kassandra I Alcaraz, Rachel S Cannady, Richard C Wender, Otis W Brawley
Cancer care delivery is being shaped by growing numbers of cancer survivors coupled with provider shortages, rising costs of primary treatment and follow-up care, significant survivorship health disparities, increased reliance on informal caregivers, and the transition to value-based care. These factors create a compelling need to provide coordinated, comprehensive, personalized care for cancer survivors in ways that meet survivors' and caregivers' unique needs while minimizing the impact of provider shortages and controlling costs for health care systems, survivors, and families...
October 30, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30303518/a-blueprint-for-the-primary-prevention-of-cancer-targeting-established-modifiable-risk-factors
#6
Susan M Gapstur, Jeffrey M Drope, Eric J Jacobs, Lauren R Teras, Marjorie L McCullough, Clifford E Douglas, Alpa V Patel, Richard C Wender, Otis W Brawley
In the United States, it is estimated that more than 1.7 million people will be diagnosed with cancer, and more than 600,000 will die of the disease in 2018. The financial costs associated with cancer risk factors and cancer care are enormous. To substantially reduce both the number of individuals diagnosed with and dying from cancer and the costs associated with cancer each year in the United States, government and industry and the public health, medical, and scientific communities must work together to develop, invest in, and implement comprehensive cancer control goals and strategies at the national level and expand ongoing initiatives at the state and local levels...
October 10, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30300452/better-guidelines-needed-for-cancer-survivorship-management
#7
Mike Fillon
No abstract text is available yet for this article.
October 9, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30298902/smoking-cessation-aids-alone-do-not-help-smokers-quit
#8
Mike Fillon
No abstract text is available yet for this article.
October 9, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30295930/gastroenteropancreatic-neuroendocrine-tumors
#9
REVIEW
Mauro Cives, Jonathan R Strosberg
Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse neuroendocrine system. They frequently originate in the gastroenteropancreatic (GEP) tract and the bronchopulmonary tree, and their incidence has steadily increased in the last 3 decades. Fundamental biologic and genomic differences underlie the clinical heterogeneity of NETs, and distinct molecular features characterize NETs of different grades and different primary sites. Although surgery remains the cornerstone of treatment for localized tumors, systemic treatment options for patients with metastatic NETs have expanded considerably...
October 8, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30285281/cancer-statistics-for-hispanics-latinos-2018
#10
Kimberly D Miller, Ann Goding Sauer, Ana P Ortiz, Stacey A Fedewa, Paulo S Pinheiro, Guillermo Tortolero-Luna, Dinorah Martinez-Tyson, Ahmedin Jemal, Rebecca L Siegel
Cancer is the leading cause of death among Hispanics/Latinos, who represent the largest racial/ethnic minority group in the United States, accounting for 17.8% (57.5 million) of the total population in the continental United States and Hawaii in 2016. In addition, more than 3 million Hispanic Americans live in the US territory of Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanics in the United States based on data from the National Cancer Institute, the North American Association of Central Cancer Registries, and the Centers for Disease Control and Prevention...
October 4, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30240520/hypercalcemia-and-cancer-differential-diagnosis-and-treatment
#11
Jonathan Zagzag, Mimi I Hu, Sarah B Fisher, Nancy D Perrier
Incidentally detected hypercalcemia usually presents in an indolent manner and is most likely caused by primary hyperparathyroidism. In contrast, hypercalcemia in the patient with a history of cancer presents in a wide range of clinical settings and may be severe enough to warrant hospitalization. This form of hypercalcemia is usually secondary to hypercalcemia of malignancy and can be fatal. Hypercalcemia of malignancy is most commonly mediated by tumoral production of parathyroid hormone-related protein or by cytokines activating osteoclast degradation of bone...
September 21, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30229871/frequent-use-of-tests-to-monitor-metastatic-prostate-cancer-often-may-be-unwarranted
#12
(no author information available yet)
No abstract text is available yet for this article.
September 19, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30229868/exercise-and-nutrition-may-prolong-the-lives-of-patients-with-colon-cancer
#13
Mike Fillon
No abstract text is available yet for this article.
September 19, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30328620/local-cancer-recurrence-the-realities-challenges-and-opportunities-for-new-therapies
#14
REVIEW
David A Mahvi, Rong Liu, Mark W Grinstaff, Yolonda L Colson, Chandrajit P Raut
Locoregional recurrence negatively impacts both long-term survival and quality of life for several malignancies. For appropriate-risk patients with an isolated, resectable, local recurrence, surgery represents the only potentially curative therapy. However, oncologic outcomes remain inferior for patients with locally recurrent disease even after macroscopically complete resection. Unfortunately, these operations are often extensive, with significant perioperative morbidity and mortality. This review highlights selected malignancies (mesothelioma, sarcoma, lung cancer, breast cancer, rectal cancer, and peritoneal surface malignancies) in which surgical resection is a key treatment modality and local recurrence plays a significant role in overall oncologic outcome with regard to survival and quality of life...
November 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30207593/global-cancer-statistics-2018-globocan-estimates-of-incidence-and-mortality-worldwide-for-36-cancers-in-185-countries
#15
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11...
September 12, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30303534/toward-the-control-of-cancer
#16
EDITORIAL
Otis W Brawley, Ted Gansler, Richard C Wender
No abstract text is available yet for this article.
September 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30277572/improving-patient-and-caregiver-outcomes-in-oncology-team-based-timely-and-targeted-palliative-care
#17
REVIEW
David Hui, Breffni L Hannon, Camilla Zimmermann, Eduardo Bruera
Over the past decade, a large body of evidence has accumulated supporting the integration of palliative care into oncology practice for patients with advanced cancer. The question is no longer whether palliative care should be offered, but what is the optimal model of delivery, when is the ideal time to refer, who is in greatest need of a referral, and how much palliative care should oncologists themselves be providing. These questions are particularly relevant given the scarcity of palliative care resources internationally...
September 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29985544/update-on-infection-control-practices-in-cancer-hospitals
#18
REVIEW
Ella J Ariza-Heredia, Roy F Chemaly
Therapies in oncology have evolved rapidly over the last years. At the same pace, supportive care for patients receiving cancer therapy has also evolved, allowing patients to safely receive the newest advances in treatment in both an inpatient and outpatient basis. The recognition of the role of infection control and prevention (ICP) in the outcomes of patients living with cancer has been such that it is now a requirement for hospitals and involves multidisciplinary groups. Some unique aspects of ICP for patients with cancer that have gained momentum over the past few decades include catheter-related infections, multidrug-resistant organisms, community-acquired viral infections, and the impact of the health care environment on the horizontal transmission of organisms...
September 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30191964/an-assessment-of-progress-in-cancer-control
#19
Rebecca L Siegel, Ahmedin Jemal, Richard C Wender, Ted Gansler, Jiemin Ma, Otis W Brawley
This article summarizes cancer mortality trends and disparities based on data from the National Center for Health Statistics. It is the first in a series of articles that will describe the American Cancer Society's vision for how cancer prevention, early detection, and treatment can be transformed to lower the cancer burden in the United States, and sets the stage for a national cancer control plan, or blueprint, for the American Cancer Society goals for reducing cancer mortality by the year 2035. Although steady progress in reducing cancer mortality has been made over the past few decades, it is clear that much more could, and should, be done to save lives through the comprehensive application of currently available evidence-based public health and clinical interventions to all segments of the population...
July 10, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/30152865/reducing-social-inequalities-in-cancer-setting-priorities-for-research
#20
Salvatore Vaccarella, Joannie Lortet-Tieulent, Rodolfo Saracci, Miranda M Fidler, David I Conway, Nadia Vilahur, Diana Sarfati, Ahmedin Jemal, Johan P Mackenbach, Michael G Marmot, Kurt Straif, Christopher P Wild
No abstract text is available yet for this article.
July 10, 2018: CA: a Cancer Journal for Clinicians
journal
journal
20065
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"